MMA
BSX icon

Miracle Mile Advisors’s Boston Scientific BSX Stock Holding History

Miracle Mile Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Sell
14,137
-19,240
-58% -$1.04M 0.01% 567
2026
Q1 		$2.09M Buy
33,377
+3,670
+12% +$294K 0.03% 297
2025
Q4 		$2.83M Buy
29,707
+773
+3% +$75.8K 0.04% 257
2025
Q3 		$2.82M Buy
28,934
+3,750
+15% +$388K 0.04% 252
2025
Q2 		$2.7M Buy
25,184
+19,159
+318% +$1.94M 0.05% 220
2025
Q1 		$608K Buy
6,025
+527
+10% +$53.1K 0.01% 401
2024
Q4 		$491K Buy
5,498
+246
+5% +$21.7K 0.01% 440
2024
Q3 		$440K Buy
5,252
+203
+4% +$16K 0.01% 371
2024
Q2 		$389K Buy
5,049
+65
+1% +$4.76K 0.01% 371
2024
Q1 		$341K Buy
4,984
+185
+4% +$11.9K 0.01% 388
2023
Q4 		$277K Sell
4,799
-31
-0.6% -$1.66K 0.01% 405
2023
Q3 		$255K Buy
+4,830
New +$253K 0.01% 417

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Miracle Mile Advisors's BSX Position: Q2 2026 in Review

Miracle Mile Advisors reduced its Boston Scientific (BSX) stake by 58% in Q2 2026, selling an estimated $1.04M and leaving 14,137 shares worth $603K. The position accounts for 0.01% of the portfolio, ranked #567.

Miracle Mile Advisors first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.83M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Miracle Mile Advisors held 14,137 shares of Boston Scientific worth $603K as of Q2 2026.
  • Miracle Mile Advisors sold 19,240 Boston Scientific shares in Q2 2026, an estimated $1.04M.
  • Boston Scientific made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #567 holding.
  • Miracle Mile Advisors first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • Miracle Mile Advisors's Boston Scientific position peaked at $2.83M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.